Characterization of Intracranial Atherosclerotic Stenosis Using HR MRI

使用 HR MRI 表征颅内动脉粥样硬化性狭窄

基本信息

  • 批准号:
    8111529
  • 负责人:
  • 金额:
    $ 17.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-05-01 至 2016-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The candidate is a fellowship-trained academic vascular neurologist with a long-term goal of becoming an independent clinical stroke researcher focused on understanding factors which influence the development and progression of intracranial atherosclerosis and influence the risk of recurrent stroke. This application proposes a comprehensive training plan which includes i.) didactic training in clinical research methodology, ii.) training in MRI imaging and vascular biology, and iii.) hands-on experience in clinical research by participating in a supervised leadership role in an NIH-funded clinical trial and completion of a mentored research project. The goal of this mentored research project is to develop a validated approach to characterize intracranial atherosclerotic plaque components using HR MRI which will be used as both a.) a clinical tool for risk stratification and a marker for disease activity and b.) a research tool to further study atherosclerotic plaque development and progression. Intracranial atherosclerosis is a leading cause of stroke, but little is known about the composition of the intracranial atherosclerotic lesion and how intracranial plaque morphology is related to the risk of stroke. There is no established in vivo model for characterizing intracranial plaque components, but the use of high resolution magnetic resonance imaging (HR MRI) in patients with extracranial carotid atherosclerosis has shown this technique can identify histologically-defined plaque components (i.e. intraplaque hemorrhage, fibrous cap, and lipid core) with high inter-rater agreement and that these plaque components are predictors of recurrent stroke. The candidate's pilot data has demonstrated that features of atherosclerotic plaque can be visualized in the intracranial arteries using HR MRI. This study aims to refine a HR MRI imaging protocol by systematically altering sequence parameters in a step-wise fashion in 36 patients in order to define a protocol that will consistently visualize intracranial atherosclerotic plaque components (Part 1 of this proposal). This will be followed by a prospective observational study of 90 patients, which aims to demonstrate high inter-rater agreement for identifying intracranial plaque components on HR MRI, determine the frequency of these components in symptomatic vs. asymptomatic plaques, and estimate the 1 year rate of stroke in the territory of high risk plaque components (Part 2 of this proposal). Additionally, a comparison of HR MRI-defined plaque components and post-mortem vascular histology will be performed in patients who die of acute stroke from intracranial stenosis. After establishing the reliability and validity of these measures, the candidate will submit an R01 grant application to determine the prevalence and prognosis of intracranial atherosclerotic plaque components in a multicenter study using the HR MRI protocol defined in the K23. These studies will lead to new understanding of the pathophysiological mechanisms of cerebral ischemia in patients with atherosclerotic intracranial stenosis, improvements in risk stratification, and potentially to new treatments of this common and serious disease. PUBLIC HEALTH RELEVANCE: Project Narrative This project will evaluate the use of high-resolution (HR) MRI for identifying atherosclerotic plaque components in patients with intracranial atherosclerosis. Establishing that HR MRI is a useful in-vivo tool for determining intracranial plaque composition could lead to new understanding of the pathophysiological mechanisms of cerebral ischemia in patients with atherosclerotic intracranial stenosis as well as improvements in risk stratification and treatment of this common disease.
描述(由申请人提供):候选人是一名经过奖学金培训的学术血管神经学家,其长期目标是成为一名独立的临床卒中研究人员,专注于了解影响颅内动脉粥样硬化发展和进展以及影响复发性卒中风险的因素。本申请提出了一个全面的培训计划,其中包括i.)临床研究方法学的教学培训,ii.)MRI成像和血管生物学方面的培训,以及iii.)通过参与NIH资助的临床试验中的监督领导角色并完成指导研究项目,获得临床研究的实践经验。本指导研究项目的目标是开发一种经验证的方法,使用HR MRI表征颅内动脉粥样硬化斑块成分,该方法将用作a.)用于风险分层的临床工具和疾病活动性的标志物,和B.)进一步研究动脉粥样硬化斑块发展和进展的研究工具。 颅内动脉粥样硬化是脑卒中的主要原因,但对颅内动脉粥样硬化病变的组成以及颅内斑块形态与脑卒中风险的关系知之甚少。目前还没有确定的颅内斑块成分的体内模型,但高分辨率磁共振成像(HR MRI)在颅外颈动脉粥样硬化患者中的应用表明,该技术可以识别组织学定义的斑块成分(即斑块内出血、纤维帽和脂质核心),评分者之间的一致性很高,这些斑块成分是复发性卒中的预测因子。候选人的试点数据表明,动脉粥样硬化斑块的特征可以使用HR MRI在颅内动脉中可视化。本研究旨在通过在36例患者中以逐步方式系统性改变序列参数来完善HR MRI成像方案,以定义一种能够持续显示颅内动脉粥样硬化斑块成分的方案(本提案的第1部分)。随后将进行一项90例患者的前瞻性观察性研究,旨在证明HR MRI上识别颅内斑块成分的高评价者间一致性,确定这些成分在症状性与无症状性斑块中的频率,并估计高风险斑块成分区域的1年卒中发生率(本提案第2部分)。此外,将在因颅内狭窄而死于急性卒中的患者中比较HR MRI定义的斑块成分和死后血管组织学。在确定这些测量的可靠性和有效性后,候选人将提交R01资助申请,以使用K23中定义的HR MRI方案在多中心研究中确定颅内动脉粥样硬化斑块成分的患病率和预后。这些研究将导致对动脉粥样硬化性颅内狭窄患者脑缺血的病理生理机制的新认识,改善风险分层,并可能为这种常见和严重疾病提供新的治疗方法。 公共卫生关系:项目叙述本项目将评价使用高分辨率(HR)MRI识别颅内动脉粥样硬化患者的动脉粥样硬化斑块成分。确定HR MRI是确定颅内斑块成分的有用体内工具,可能会导致对动脉粥样硬化性颅内狭窄患者脑缺血病理生理机制的新理解,以及这种常见疾病的风险分层和治疗的改进。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TANYA N TURAN其他文献

TANYA N TURAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TANYA N TURAN', 18)}}的其他基金

Southeast Collaborative Alliance for Stroke Trials (SE-CoAST)
东南卒中试验合作联盟 (SE-CoAST)
  • 批准号:
    10448518
  • 财政年份:
    2018
  • 资助金额:
    $ 17.19万
  • 项目类别:
Southeast Collaborative Alliance for Stroke Trials (SE-CoAST)
东南卒中试验合作联盟 (SE-CoAST)
  • 批准号:
    10306027
  • 财政年份:
    2018
  • 资助金额:
    $ 17.19万
  • 项目类别:
Southeast Collaborative Alliance for Stroke Trials (SE-CoAST)
东南卒中试验合作联盟 (SE-CoAST)
  • 批准号:
    9762233
  • 财政年份:
    2018
  • 资助金额:
    $ 17.19万
  • 项目类别:
China-America MRI Plaque Imaging & Outcome Network (ChAMPION)
中美MRI斑块成像
  • 批准号:
    9138967
  • 财政年份:
    2015
  • 资助金额:
    $ 17.19万
  • 项目类别:
China-America MRI Plaque Imaging & Outcome Network (ChAMPION)
中美MRI斑块成像
  • 批准号:
    8992144
  • 财政年份:
    2015
  • 资助金额:
    $ 17.19万
  • 项目类别:
Characterization of Intracranial Atherosclerotic Stenosis Using HR MRI
使用 HR MRI 表征颅内动脉粥样硬化性狭窄
  • 批准号:
    8252172
  • 财政年份:
    2011
  • 资助金额:
    $ 17.19万
  • 项目类别:
Characterization of Intracranial Atherosclerotic Stenosis Using HR MRI
使用 HR MRI 表征颅内动脉粥样硬化性狭窄
  • 批准号:
    8824582
  • 财政年份:
    2011
  • 资助金额:
    $ 17.19万
  • 项目类别:
Characterization of Intracranial Atherosclerotic Stenosis Using HR MRI
使用 HR MRI 表征颅内动脉粥样硬化性狭窄
  • 批准号:
    8465293
  • 财政年份:
    2011
  • 资助金额:
    $ 17.19万
  • 项目类别:
Characterization of Intracranial Atherosclerotic Stenosis Using HR MRI
使用 HR MRI 表征颅内动脉粥样硬化性狭窄
  • 批准号:
    8658858
  • 财政年份:
    2011
  • 资助金额:
    $ 17.19万
  • 项目类别:

相似海外基金

A study for cross borders Indonesian nurses and care workers: Case of Japan-Indonesia Economic Partnership Agreement
针对跨境印度尼西亚护士和护理人员的研究:日本-印度尼西亚经济伙伴关系协定的案例
  • 批准号:
    22KJ0334
  • 财政年份:
    2023
  • 资助金额:
    $ 17.19万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
NSF-NOAA Interagency Agreement (IAA) for the Global Oscillations Network Group (GONG)
NSF-NOAA 全球振荡网络组 (GONG) 机构间协议 (IAA)
  • 批准号:
    2410236
  • 财政年份:
    2023
  • 资助金额:
    $ 17.19万
  • 项目类别:
    Cooperative Agreement
Conditions for U.S. Agreement on the Closure of Contested Overseas Bases: Relations of Threat, Alliance and Base Alternatives
美国关于关闭有争议的海外基地协议的条件:威胁、联盟和基地替代方案的关系
  • 批准号:
    23K18762
  • 财政年份:
    2023
  • 资助金额:
    $ 17.19万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
MSI Smart Manufacturing Data Hub – Open Calls Grant Funding Agreement
MSI 智能制造数据中心 – 公开征集赠款资助协议
  • 批准号:
    900240
  • 财政年份:
    2023
  • 资助金额:
    $ 17.19万
  • 项目类别:
    Collaborative R&D
Challenges of the Paris Agreement Exposed by the Energy Shift by External Factors: The Case of Renewable Energy Policies in Japan, the U.S., and the EU
外部因素导致的能源转移对《巴黎协定》的挑战:以日本、美国和欧盟的可再生能源政策为例
  • 批准号:
    23H00770
  • 财政年份:
    2023
  • 资助金额:
    $ 17.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Continuation of Cooperative Agreement between U.S. Food and Drug Administration and S.C. Department of Health and Environmental Control (DHEC) for MFRPS Maintenance.
美国食品和药物管理局与南卡罗来纳州健康与环境控制部 (DHEC) 继续签订 MFRPS 维护合作协议。
  • 批准号:
    10829529
  • 财政年份:
    2023
  • 资助金额:
    $ 17.19万
  • 项目类别:
National Ecological Observatory Network Governing Cooperative Agreement
国家生态观测站网络治理合作协议
  • 批准号:
    2346114
  • 财政年份:
    2023
  • 资助金额:
    $ 17.19万
  • 项目类别:
    Cooperative Agreement
The Kansas Department of Agriculture's Flexible Funding Model Cooperative Agreement for MFRPS Maintenance, FPTF, and Special Project.
堪萨斯州农业部针对 MFRPS 维护、FPTF 和特别项目的灵活资助模式合作协议。
  • 批准号:
    10828588
  • 财政年份:
    2023
  • 资助金额:
    $ 17.19万
  • 项目类别:
Robust approaches for the analysis of agreement between clinical measurements: development of guidance and software tools for researchers
分析临床测量之间一致性的稳健方法:为研究人员开发指南和软件工具
  • 批准号:
    MR/X029301/1
  • 财政年份:
    2023
  • 资助金额:
    $ 17.19万
  • 项目类别:
    Research Grant
FER (H&L) AMR PACE (A-0438) grant funding agreement
费率(H
  • 批准号:
    107541
  • 财政年份:
    2023
  • 资助金额:
    $ 17.19万
  • 项目类别:
    Collaborative R&D
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了